Elsevier

Brain Research

Volume 604, Issues 1–2, 26 February 1993, Pages 1-6
Brain Research

Effects of administration of ciliary neurotrophic factor on normal motor and sensory peripheral nerves in vivo

https://doi.org/10.1016/0006-8993(93)90345-NGet rights and content

Abstract

Ciliary neurotrophic factor (CNTF) has a variety of effects on different neuronal populations in vitro, but little has been reported concerning its effects in vivo. This study examined the effects of CNTF administration on peripheral nerves both in young growing rats and in more mature animals. In both young and fully grown rats, CNTF stimulated levels of substance P and calcitonin gene related peptide in sensory spinal ganglia. In immature rats, CNTF increased compound nerve conduction velocity and motor nerve conduction velocity. By contrast, electrophysiological measurements were not affected in fully grown animals. There was a biphasic dose response to CNTF for the electrophysiologic changes with larger changes noted at a dose of 0.1 μg/g body weight than at a dose of 0.25 μg/g. There were no behavioral changes noted at either dose of the factor. These observations indicate that CNTF administration in vivo can influence neural physiology, and suggest that the factor may be useful for the treatment of disorders involving either sensory or motor peripheral nerves.

References (15)

There are more references available in the full text version of this article.

Cited by (34)

  • Neurotrophic factors

    2008, CNS Regeneration
  • Neurotrophic Factors

    2007, CNS Regeneration: Basic Science and Clinical Advances
  • Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease

    2004, Brain Research
    Citation Excerpt :

    The beneficial effect with a higher dose of BDNF (40 mg/kg) appeared to be similar to or temporarily less than that with 20 mg/kg during 4 weeks of treatment. Similar biphasic dose-related effects on sensory and motor neurons have been seen with neurotrophic factors such as nerve-growth factor [10], ciliary neurotrophic factor [2], and BDNF [50]. Because of this kind of dose–response pattern, it is critical to establish the appropriate therapeutic dose to elicit the maximum beneficial effect of BDNF.

View all citing articles on Scopus
View full text